1Lorber D.GLP-1 receptor agonists:effects on cardiovascular risk reduction[J].Cardiovasc Ther,2013,18(31):238-249.
2Katout M,Zhu H,Rutsky J,et al.Effect of GLP-1 mimetics on blood pressure and relationship to weight loss and glycemic lowering:results of a systematic meta-analysis and meta-regression[J].Am J Hypertens,2014,330(27):130-139.
3Neal B,Perkovic V,de Zeeuw D,et al.Rationale,design,and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study(CANVAS)-a randomized placebocontrolled trial[J].Am Heart J,2013,27(166):227.
